Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-076993
Filing Date
2025-05-23
Accepted
2025-05-23 16:30:05
Documents
1
Period of Report
2025-05-23

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4020
  Complete submission text file 0000950170-25-076993.txt   5498
Mailing Address C/O KYMERA THERAPEUTICS, INC. 200 ARSENAL YARDS BLVD., SUITE 230 WATERTOWN MA 02472
Business Address
Chadwick Jeremy G (Reporting) CIK: 0001388406 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39460 | Film No.: 25982831

Mailing Address 500 NORTH BEACON STREET, 4TH FLOOR WATERTOWN MA 02472
Business Address 500 NORTH BEACON STREET, 4TH FLOOR WATERTOWN MA 02472 857-285-5314
Kymera Therapeutics, Inc. (Issuer) CIK: 0001815442 (see all company filings)

EIN.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)